454 related articles for article (PubMed ID: 30987527)
1. A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
Huang Y; Cen J; Liu Z; Wei J; Chen Z; Feng Z; Lu J; Fang Y; Zhou F; Luo J; Mo C; Chen W
Technol Cancer Res Treat; 2019 Jan; 18():1533033819844483. PubMed ID: 30987527
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Aizawa M; Tochigi T; Kawamura S; Aoki H; Numata I; Takeda A; Namiki S; Namima T; Ikeda Y; Kambe K; Kyan A; Ueno S; Orikasa K; Katoh S; Adachi H; Tokuyama S; Ishidoya S; Yamaguchi T; Arai Y
J Clin Oncol; 2013 Apr; 31(11):1422-7. PubMed ID: 23460707
[TBL] [Abstract][Full Text] [Related]
3. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
[TBL] [Abstract][Full Text] [Related]
4. The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.
Yuan H; Mao X; Bai Y; Li H; Liu L; Pu C; Li J; Tang Y; Wei Q; Han P
J Chemother; 2015 Aug; 27(4):195-200. PubMed ID: 25968487
[TBL] [Abstract][Full Text] [Related]
5. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
Massari M; O'Malley P; Benidir T; Su LM; Gao H; Crispen PL
Urol Oncol; 2024 Sep; 42(9):289.e7-289.e12. PubMed ID: 38802293
[TBL] [Abstract][Full Text] [Related]
7. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
[TBL] [Abstract][Full Text] [Related]
8. A Phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III).
Miyamoto K; Ito A; Wakabayashi M; Eba J; Arai Y; Nishiyama H; Sugimoto M; Yamashita R; Kakehi Y
Jpn J Clin Oncol; 2018 Jan; 48(1):94-97. PubMed ID: 29136187
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy.
Freifeld Y; Ghandour R; Singla N; Woldu S; Bagrodia A; Lotan Y; Rapoport LM; Gazimiev M; Delafuente K; Kulangara R; Robyak H; Petros FG; Raman JD; Matin SF; Margulis V
Urol Oncol; 2020 Sep; 38(9):737.e11-737.e16. PubMed ID: 32641241
[TBL] [Abstract][Full Text] [Related]
10. Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma.
Hwang EC; Sathianathen NJ; Jung JH; Kim MH; Dahm P; Risk MC
Cochrane Database Syst Rev; 2019 May; 5(5):CD013160. PubMed ID: 31102534
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].
Isbarn H; Budäus L; Pichlmeier U; Conrad S; Huland H; Friedrich MG
Urologe A; 2008 May; 47(5):608-15. PubMed ID: 18317718
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis.
Wu P; Zhu G; Wei D; Liu S; Walsh K; Li D; Harron U; Wang X; Ma H; Wan B; Sun L; Yang Z; Wang J
J BUON; 2015; 20(5):1229-38. PubMed ID: 26537069
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
[TBL] [Abstract][Full Text] [Related]
14. Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy.
Maeyama R; Ikeda M; Shimura S; Amano N; Murakami Y; Yamada Y; Koguchi D; Tachibana T; Kawamura M; Sakata Y; Hagiwara M; Matsumoto K; Iwamura M
Chemotherapy; 2023; 68(4):190-196. PubMed ID: 35390791
[TBL] [Abstract][Full Text] [Related]
15. Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?
Lai S; Wu P; Diao T; Seery S; Liu J; Hou H; Liu M; Wang J
Jpn J Clin Oncol; 2021 Mar; 51(3):469-477. PubMed ID: 32734304
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis.
Fang D; Li XS; Xiong GY; Yao L; He ZS; Zhou LQ
Urol Int; 2013; 91(3):291-6. PubMed ID: 23948770
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy.
Moriarty MA; Uhlman MA; Bing MT; O'Donnell MA; Brown JA; Tracy CR; Deorah S; Nepple KG; Gupta A
BMC Urol; 2015 May; 15():45. PubMed ID: 26018765
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy.
Long X; Zu X; Li Y; He W; Hu X; Tong S; Wang Z; Chen M; Qi L
PLoS One; 2016; 11(11):e0166884. PubMed ID: 27870887
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Therapeutic Benefit and Option Strategy on Intravesical Instillation for Preventing Bladder Cancer Recurrence after Radical Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma.
Fan B; Teng Q; Sun M; Wang Y; Wang Y; Lin Z; Wang Y; Duan X; Zhang L; Chen T; Chen S; Tai Y; Zhang C; Song X; Liu Z
J Oncol; 2022; 2022():1755368. PubMed ID: 35677889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]